Cynvenio is dedicated to developing tools to enable the early detection, longitudinal monitoring and targeted treatment of cancer.
Learn More About Us →
ClearID® liquid biopsy testing by Cynvenio provides physicians with real-time, actionable insights to support personalized treatment paths.
Get Started With ClearID →
The LiquidBiopsy® platform enables the isolation, enumeration, and molecular analysis of rare cells and cell-free DNA from whole-blood samples.
Learn About Our Platform →
Learn about Cynvenio's LiquidBiopsy workflow using the Ion S5 sequencer. >>